Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Triffin who wrote (1080)	11/5/1998 11:42:00 PM
From: Louis Riley	Read Replies (1) \| Respond to of 3576

Probably because the officers all needed to dump shares again, like they did the last time they hyped the stock (Januury 13 and 14, 1998). If you doubt me, check the Federal 144 filings. These guys are some of the best traders I've ever seen.

To: Triffin who wrote (1080)	11/6/1998 1:27:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3576

>> Are there any other public plays in this sector??? << Jim: Specifically in human stem cells?.......... anything that is not lineage-specific (i.e., makes only a given tissue such as muscle) probably will bounce up against the GERN patent estate. There are good plays on porcine (pig) pluripotent stem cells, very good plays. Pigs are a likely source of organs (kidneys, etc.) for future transplants. There is a company that specializes in mesenchymal (human) stem cells. I'm trying to remember the name of it. If I find it, I'll report back before the open tomorrow. Not really relevant, IMO, but with this freaking circus, it certainly couldn't lose one much more than commisions. ;-) BTW..... for those that feel that this is a new observation...... please note that this post was made in October, but October 1997........ exchange2000.com Mike Iles had this news over a year ago. Rick